Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
896.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.222%)
Market Cap: £128.91b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Further re Capital reduction

30 Dec 2025 16:32

RNS Number : 1925N
Banco Santander S.A.
30 December 2025
Β 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Further to the notice of other relevant information registered with the Spanish National Securities Market Commission (ComisiΓ³n Nacional del Mercado de Valores) on 23 December 2025 (registry numberΒ 38297), it is communicated that on 30 December 2025 the public deed of capital reduction (and consequent Bylaw amendment) for the amount of EURΒ 98,002,935, through the cancellation of 196,005,870Β own shares, representing approximately 1.32% of the Bank's share capital, was registered with the Commercial Registry of Santander.

Consequently, the Bank's share capital has been set at EURΒ 7,344,659,751, represented by 14,689,319,502Β shares with a nominal value of EUR 0.50 each. All of the shares belong to the same class and have the same rights.

It is stated for the record that, once the nine buyback programmes carried out against results since 2021 have been completed, the accumulated share capital reduction amounts to EUR 1,325,660,900, with the Bank having repurchased 2,651,321,800Β shares sinceΒ 2021, approximately 15.3% of its outstanding shares as of that date.

Boadilla del Monte (Madrid), 30Β December 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FURWPGRPPUPAGQU
Date   Source Headline
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb
18th Feb 20264:48 pmRNSDirector/PDMR Shareholding
18th Feb 202611:07 amRNSInvestor Day meeting announcement
12th Feb 20263:02 pmRNSBuyback programme: transactions 4-11Feb
10th Feb 20265:09 pmRNSChanges to the presentation of Group’s information
5th Feb 20265:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.